Abstract
PARP1 inhibitors (PARPis) are used clinically during cancer therapy and are thought to exert their cytotoxicity through PARP1 polymerase inhibition an......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
